These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 7758507

  • 1. Technetium-99m exametazime (99mTc-HMPAO)-labeled white blood cells: a high efficiency multidose procedure.
    Ozker K, Collier BD, Hellman RS, Isitman AT, Uzum F, Steffel FG.
    Eur J Nucl Med; 1995 Feb; 22(2):182-3. PubMed ID: 7758507
    [No Abstract] [Full Text] [Related]

  • 2. 99mTc-HM-PAO: a single dosis preparation for blood cell.
    Piera C, Pavía A, Catafau A, Muxí A, Lomeña F, Pons F.
    Prog Clin Biol Res; 1990 Feb; 355():115-8. PubMed ID: 2281092
    [No Abstract] [Full Text] [Related]

  • 3. 99mTc labeling white blood cells with a simple technique: clinical application.
    Gutfilen B, Pellini MP, de Roure e Neder J, de Amarante Júnior JL, Evangelista MG, Fernandes SR, Bernardo-Filho M.
    Ann Nucl Med; 1994 Feb; 8(1):85-9. PubMed ID: 8204402
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of a new leukocyte labeling procedure with 99mTc-HMPAO.
    Kelbaek H, Linde J, Nielsen SL.
    Eur J Nucl Med; 1988 Feb; 14(12):621-3. PubMed ID: 3243309
    [Abstract] [Full Text] [Related]

  • 5. Effect of granulocyte concentration on leukocyte labelling efficiency with 99mTc-HMPAO.
    Ballinger JR, Proulx A, Gerson B, Gulenchyn KY.
    Int J Rad Appl Instrum B; 1990 Feb; 17(4):443. PubMed ID: 2387752
    [No Abstract] [Full Text] [Related]

  • 6. In vitro comparison of HMPAO and gentisic acid for labelling leukocytes with 99mTc.
    Ecclestone M, Proulx A, Ballinger JR, Gerson B, Reid RH, Gulenchyn KY.
    Eur J Nucl Med; 1990 Feb; 16(4-6):299-302. PubMed ID: 2161770
    [Abstract] [Full Text] [Related]

  • 7. Leukocyte labeling with 99mTc-HMPAO. The role of the in vitro stability of HMPAO on the labeling efficacy and image quality.
    Papós M, Láng J, Rajtár M, Csernay L.
    Nucl Med Biol; 1994 Aug; 21(6):893-5. PubMed ID: 9234340
    [No Abstract] [Full Text] [Related]

  • 8. New synthesis route of active substance d,l-HMPAO for preparation Technetium Tc99m Exametazime.
    Pijarowska-Kruszyna J, Karczmarczyk U, Jaroń AW, Laszuk E, Radzik M, Garnuszek P, Mikołajczak R.
    Nucl Med Rev Cent East Eur; 2017 Aug; 20(2):88-94. PubMed ID: 28555448
    [Abstract] [Full Text] [Related]

  • 9. Simple procedure for red blood cell labeling with Tc-99m HMPAO. Preliminary clinical results.
    Vorne M, Laitinen R.
    Clin Nucl Med; 1992 Jan; 17(1):14-7. PubMed ID: 1311998
    [Abstract] [Full Text] [Related]

  • 10. Morphological and functional status of leukocytes labelled with 99m technetium HMPAO.
    De Labriolle-Vaylet C, Linhart NC, Petiet A, Bok B.
    Prog Clin Biol Res; 1990 Jan; 355():119-29. PubMed ID: 2177895
    [No Abstract] [Full Text] [Related]

  • 11. A method for stabilising technetium-99m exametazime prepared from a commercial kit.
    Weisner PS, Bower GR, Dollimore LA, Forster AM, Higley B, Storey AE.
    Eur J Nucl Med; 1993 Aug; 20(8):661-6. PubMed ID: 8404951
    [Abstract] [Full Text] [Related]

  • 12. A comparative study of 99Tcm-HMPAO and 99Tcm-ECD as a leukocyte labelling agent.
    Kao CH, Huang WT, Wang YL, Lin KS, Lo JM, Wang SJ.
    Nucl Med Commun; 1994 Apr; 15(4):294-7. PubMed ID: 8072744
    [Abstract] [Full Text] [Related]

  • 13. Red blood cells labelling with 99mTc-HM-PAO.
    Piera C, Bassa P, García JR, Catafau A, Moragas M, Muxí A, Pavía A, Lomeña F.
    Prog Clin Biol Res; 1990 Apr; 355():131-4. PubMed ID: 2281093
    [No Abstract] [Full Text] [Related]

  • 14. A comparative study of 99Tcm-d,l-HMPAO and 99Tcm-d,l-CBPAO as leukocyte-labelling agents.
    Tsai CS, Kao CH, Yeh SJ, Wang SJ.
    Nucl Med Commun; 1996 Jan; 17(1):76-9. PubMed ID: 8692477
    [Abstract] [Full Text] [Related]

  • 15. [99mTc-HMPAO labeling of leukocytes and thrombocytes. Characteristics and diagnostic consequences].
    Becker W, Börner W.
    Rofo; 1988 Jan; 148(1):69-74. PubMed ID: 2829311
    [Abstract] [Full Text] [Related]

  • 16. Use of stabilized technetium-99m-exametazime for radiolabeling leukocytes.
    Hung JC, Chowdhury S, Mullan BP.
    J Nucl Med; 1998 May; 39(5):912-7. PubMed ID: 9591600
    [Abstract] [Full Text] [Related]

  • 17. Radiochemical purity of technetium-99m-HMPAO depends on specific activity.
    Piera C, Martínez A, Ramírez I.
    J Nucl Med; 1995 Apr; 36(4):706. PubMed ID: 7699470
    [No Abstract] [Full Text] [Related]

  • 18. Technetium-99m-HMPAO-labeled leukocytes and technetium-99m-labeled human polyclonal immunoglobulin G in diagnosis of focal purulent disease.
    Hovi I, Taavitsainen M, Lantto T, Vorne M, Paul R, Remes K.
    J Nucl Med; 1993 Sep; 34(9):1428-34. PubMed ID: 8355059
    [Abstract] [Full Text] [Related]

  • 19. Lymphocyte labeling with technetium-99m-HMPAO: a radiotoxicity study using the micronucleus assay.
    Thierens HM, Vral AM, Van Haelst JP, Van de Wiele C, Schelstraete KH, de Ridder LI.
    J Nucl Med; 1992 Jun; 33(6):1167-74. PubMed ID: 1597733
    [Abstract] [Full Text] [Related]

  • 20. [Leukocyte scintigraphy: clinical application to inflammatory diseases and bone marrow diseases].
    Miyazaki C.
    Kaku Igaku; 1995 Jul; 32(7):703-7. PubMed ID: 7674583
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.